The Coming Wave of New Obesity-Treatment Drugs
Results from dozens of trials are due as drugmakers seek medicines that spur greater weight loss, can be taken less often or cause fewer side effects.
Related Articles
Autopsy of a Drug Withdrawal — The Case of Melphalan Flufenamide | NEJM
A December 2022 law introduced a new expedited withdrawal process for accelerated approvals. The first approval withdrawn with this pathway was that of melphalan flufenamide.
Intermittent fasting triggers interorgan communication to suppress hair follicle regeneration
Intermittent fasting halts hair follicle regeneration by activating communication between adrenal glands and niche adipocytes, which in turn selectively induces apoptosis of hair follicle stem…
JAMA Network | WhatsApp Channel
JAMA Network WhatsApp Channel. Home of JAMA, JAMA Network Open, JAMA Health Forum, and 10 specialty journals publishing the latest information shaping clinical medicine, now…
Don’t muddy waters for patients with “nurse anesthesiologist” term
A proposed District of Columbia regulation would let nurse anesthetists use the moniker to describe themselves. That will confuse and mislead patients.
From the singularity community on Reddit: OpenAI CFO Sarah Friar says the company is leaving the door open to a $2000/month subscription to its AI product which could serve as a “replacement” to hiring humans due to its PhD-level intelligence
Explore this post and more from the singularity community
What Is the Spoon Theory Metaphor for Chronic Illness?
If you live with chronic pain, you know how debilitating it can be. “Spoon theory” helps you explain and quantify the way that pain impacts…
Real-world Study Examines Optimal Sequencing for R/R Multiple Myeloma
Study reveals that waiting at least nine months before starting teclistamab in patients with RRMM exposed to BCMA-directed therapy may improve outcomes.
Design Work to Prevent Burnout | MIT Sloan Management Review
A simplified model for work design helps managers make changes that can reduce burnout.
GLP-1 receptor agonists and obesity care
The need for lifelong support has implications for individuals and public health More than a billion people worldwide are living with obesity. After many years…
U.S. Overdose Deaths Fell 17% in Just One Year
THURSDAY, Dec. 12, 2024 (HealthDay News) — In news that suggest the U.S. opioid epidemic may be easing, drug overdose deaths fell 17% between July…
